Literature DB >> 22113007

A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.

H T Nguyen1, U Torian1, K Faulk1, K Mather1, R E Engle1, E Thompson2, H L Bonkovsky3, S U Emerson1.   

Abstract

Hepatitis E virus is the aetiological agent of acute hepatitis E, a self-limiting disease prevalent in developing countries. Molecular analysis of viral genomic RNA from a chronically infected patient confirmed the recent discovery that chronic infection correlated with extensive diversification of the virus quasispecies: the hypervariable region of some virus genomes in this USA patient contained large continuous deletions and a minor proportion of genomes in faeces and serum had acquired a mammalian sequence that encoded 39 aa of S19 ribosomal protein fused to the virus non-structural protein. Genomes with this insert were selected during virus passage in cultured cells to become the predominant species, suggesting that the inserted sequence promoted virus growth. The results demonstrated that hepatitis E virus can mutate dramatically during a prolonged infection and suggests it may be important to prevent or cure chronic infections before new variants with unpredictable properties arise.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22113007      PMCID: PMC3352352          DOI: 10.1099/vir.0.037259-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b.

Authors:  Elizabeth B Haagsma; Annelies Riezebos-Brilman; Arie P van den Berg; Robert J Porte; Hubert G M Niesters
Journal:  Liver Transpl       Date:  2010-04       Impact factor: 5.799

3.  Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.

Authors:  Nassim Kamar; Cyril Garrouste; Elizabeth B Haagsma; Valérie Garrigue; Sven Pischke; Cécile Chauvet; Jérome Dumortier; Amélie Cannesson; Elisabeth Cassuto-Viguier; Eric Thervet; Filomena Conti; Pascal Lebray; Harry R Dalton; Robert Santella; Nada Kanaan; Marie Essig; Christiane Mousson; Sylvie Radenne; Anne Marie Roque-Afonso; Jacques Izopet; Lionel Rostaing
Journal:  Gastroenterology       Date:  2011-02-24       Impact factor: 22.682

4.  Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.

Authors:  Nassim Kamar; Lionel Rostaing; Florence Abravanel; Cyril Garrouste; Sebastien Lhomme; Laure Esposito; Grégoire Basse; Olivier Cointault; David Ribes; Marie Béatrice Nogier; Laurent Alric; Jean Marie Peron; Jacques Izopet
Journal:  Gastroenterology       Date:  2010-08-11       Impact factor: 22.682

Review 5.  Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood.

Authors:  Hiroaki Okamoto
Journal:  Rev Med Virol       Date:  2011-01       Impact factor: 6.989

6.  Development and evaluation of an efficient cell-culture system for Hepatitis E virus.

Authors:  Toshinori Tanaka; Masaharu Takahashi; Eiji Kusano; Hiroaki Okamoto
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

Review 7.  Recent advances in Hepatitis E virus.

Authors:  X J Meng
Journal:  J Viral Hepat       Date:  2009-12-21       Impact factor: 3.728

8.  Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Hideyuki Takahashi; Yu Hoshino; Shigeo Nagashima; Hitoshi Mizuo; Yasuyuki Yazaki; Tomofumi Takagi; Masahiro Azuma; Eiji Kusano; Norio Isoda; Kentaro Sugano; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

Review 9.  Hepatitis E virus and neurologic disorders.

Authors:  Nassim Kamar; Richard P Bendall; Jean Marie Peron; Pascal Cintas; Laurent Prudhomme; Jean Michel Mansuy; Lionel Rostaing; Frances Keane; Samreen Ijaz; Jacques Izopet; Harry R Dalton
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

Review 10.  Molecular virology of hepatitis E virus.

Authors:  Imran Ahmad; R Prasida Holla; Shahid Jameel
Journal:  Virus Res       Date:  2011-02-21       Impact factor: 3.303

View more
  37 in total

1.  Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination.

Authors:  P Shukla; H T Nguyen; K Faulk; K Mather; U Torian; R E Engle; S U Emerson
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

2.  Full-length sequence analysis of hepatitis E virus isolates: showing potential determinants of virus genotype and identity.

Authors:  Dong Yang; Mei Jiang; Min Jin; Zhigang Qiu; Weihong Cui; Zhiqiang Shen; Bo Li; Lianfeng Gong; Zhaoli Chen; Xinwei Wang; Jun-Wen Li
Journal:  Virus Genes       Date:  2013-07-26       Impact factor: 2.332

3.  Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.

Authors:  Xianfang Wu; Viet Loan Dao Thi; Peng Liu; Constantin N Takacs; Kuanhui Xiang; Linda Andrus; Jérôme Gouttenoire; Darius Moradpour; Charles M Rice
Journal:  Gastroenterology       Date:  2017-12-24       Impact factor: 22.682

Review 4.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 5.  Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Authors:  Viet Loan Dao Thi; Xianfang Wu; Charles M Rice
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

6.  Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.

Authors:  Sebastien Lhomme; Nassim Kamar; Florence Nicot; Jacques Ducos; Michael Bismuth; Valerie Garrigue; Joelle Petitjean-Lecherbonnier; Isabelle Ollivier; Elodie Alessandri-Gradt; Odile Goria; Heidi Barth; Peggy Perrin; Karine Saune; Martine Dubois; Romain Carcenac; Caroline Lefebvre; Nicolas Jeanne; Florence Abravanel; Jacques Izopet
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

Review 7.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 8.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 9.  Potential Approaches to Assess the Infectivity of Hepatitis E Virus in Pork Products: A Review.

Authors:  Nigel Cook; Martin D'Agostino; Reimar Johne
Journal:  Food Environ Virol       Date:  2017-05-03       Impact factor: 2.778

10.  Characterization of the polyproline region of the hepatitis E virus in immunocompromised patients.

Authors:  Sebastien Lhomme; Florence Abravanel; Martine Dubois; Karine Sandres-Saune; Jean-Michel Mansuy; Lionel Rostaing; Nassim Kamar; Jacques Izopet
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.